Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Teva fined €462.6M by European regulators over Copaxone patent and competition allegations
7 months ago
Pharma
Law
UCB's anti-tau Alzheimer's program fails Phase 2 primary endpoint, but highlights positive secondaries
7 months ago
R&D
Federal court backs FDA's approval of competitor to Jazz's sleep drug
7 months ago
Pharma
FDA+
‘Imitation is best form of flattery’: Regeneron CEO comments on Amgen’s Eylea biosimilar
7 months ago
R&D
Pharma
Q&A: Jade CEO talks about reverse merger and IgAN drugs
7 months ago
Startups
Deals
Gardasil demand in China sinks, and Merck expects the same next quarter
7 months ago
China
Pharma
WuXi in ‘early stages’ of CGT business review; Lonza exec becomes AGC Bio CEO
7 months ago
Manufacturing
Takeda says multiyear restructuring is 'on track'
7 months ago
R&D
Pharma
Argenx reports Vyvgart sales streak, bolstered by launch in rare neuro disorder
7 months ago
Pharma
Boehringer, Gubra stop work on obesity drug; Galapagos restarts CAR-T study
7 months ago
News Briefing
Why a prominent health tech VC keeps adjusting how it thinks about AI in healthcare
7 months ago
AI
Health Tech
Evommune raises $115M for I&I pipeline and prepares for Phase 2 results
7 months ago
Financing
Startups
AbbVie adds to T cell engager momentum, with EvolveImmune pact starting at $65M
7 months ago
Startups
Deals
Another Paragon offshoot inks reverse merger as Jade takes Aerovate’s place
7 months ago
Startups
Deals
Amgen makes pipeline cuts, but obesity plans remain the focus
7 months ago
R&D
'What are we going to stop?' Top Walgreens exec lays out the future of its healthcare business
7 months ago
Health Tech
Bristol Myers ups revenue guidance again, raising confidence in cost-cutting
7 months ago
Pharma
Corcept misses primary endpoint in supportive Cushing's syndrome study
7 months ago
R&D
Compass Pathways delays key Phase 3 psilocybin readouts, spurring 30% layoffs
7 months ago
R&D
Lexeo shares early data on Alzheimer’s gene therapy
7 months ago
R&D
Roche presents early-stage results for latest amyloid-based Alzheimer's attempt
7 months ago
R&D
AbbVie’s immunology blockbusters make up for Humira sales drop in Q3
7 months ago
Pharma
Atlas of tumors reveals in 3D how cells change into cancer
7 months ago
R&D
Discovery
Hints of impatience grow with Biogen as it tries to find a bridge to growth
7 months ago
R&D
Pharma
First page
Previous page
82
83
84
85
86
87
88
Next page
Last page